Zachary R Chalmers

7PUBLICATIONS
29CO-AUTHORS
Molecular targetsRadiation therapyKnowledge representation and reasoningPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 16, 2025
Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors.

William Yang, Qianyu Guo, Songhua Quan

|May 30, 2025
CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

Sophia M Lamperis, Kaylin M McMahon, Andrea E Calvert

|Jul 23, 2024
T3N0 Rectal Cancer: Radiation for All, None, or Some?

Zachary R Chalmers, Hannah J Roberts, Jennifer Y Wo

|Sep 20, 2023
Anki Tagger: A Generative AI Tool for Aligning Third-Party Resources to Preclinical Curriculum.

Tricia Pendergrast, Zachary Chalmers

|Jan 09, 2021
Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions.

Zachary R Chalmers, Michael C Burns, Ericka M Ebot

Pageof 2